We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Novel Interaction Between Structural and Signaling Proteins

By Biotechdaily staff writers
Posted on 20 Feb 2003
Researchers working with genetically engineered mice have identified a novel interaction between beta-spectrin, a membrane structural protein, and TGF-beta, a messenger and control protein. More...
This finding was published in the February 7, 2003, issue of Science.

Investigators from Georgetown University (Washington, DC, USA) observed that mice lacking the gene for beta-spectrin had many defects in the embryonic development of the heart, brain, and other organs. In the current study, they reported that abnormalities in the beta-spectrin gene also interfered with some functions of TGF-beta, a messenger and control protein involved in initiation of growth and embryonic differentiation such as the creation of bone and muscle as well as many types of cancer.

"Without beta-spectrin,” explained senior author Dr. Lopa Mishra, associate professor of medicine at Georgetown University, "a key molecular link which turns on a battery of genes important to development does not occur. This happens because proteins do not attach to the ‘ribwork' or inner skeleton of the cell.”

The next step will be to examine the relation of beta-spectrin to TGF-beta in humans, since specifically interrupting the interactions of beta-spectrin in the TGF pathway could represent a new approach to the treatment of cancer and disorders involving the overexpression of TGF-beta.

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.